A phase Ib/II study of leronlimab combined with carboplatin in patients with CCR5+metastatic triple-negative breast cancer (mTNBC)-MedSci.cn

A phase Ib/II study of leronlimab combined with carboplatin in patients with CCR5+metastatic triple-negative breast cancer (mTNBC)

Cristofanilli, M; Chittoria, N; Ehsani, S; Rui, H; Dolezal, M; Stork-Sloots, L; de Snoo, F; Recknor, C; Abramson, V

CANCER RESEARCH, 2022; 82 (4):

科室
- - 订阅+
  - 更多科室
工具
服务